This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christine Ju - Innovator in Cancer Prognosis
Introduction
Christine Ju is an accomplished inventor based in Pleasanton, CA (US). She has made significant contributions to the field of cancer research, particularly in the area of colorectal cancer prognosis. Although she currently holds no granted patents, her work is poised to impact the medical community significantly.
Latest Patent Applications
Christine Ju has filed several innovative patent applications. One of her latest applications is titled "Method of Cancer Prognosis by Assessing Tumor Variant Diversity." This invention focuses on predicting the response to therapy in colorectal cancer patients by measuring tumor genetic heterogeneity through the analysis of circulating tumor DNA from a patient's sample. Another notable application is "Surrogate Marker and Method for Tumor Mutation Burden Measurement." This method aims to predict the recurrence of colorectal cancer in patients following surgery by analyzing circulating tumor DNA from their samples.
Conclusion
Christine Ju's work in cancer prognosis demonstrates her commitment to advancing medical science. Her innovative approaches have the potential to improve patient outcomes in colorectal cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile